I heard Canopy Growth's Bruce Linton was forced to resigned already. His decision to invest in AusCann was probably part of his poor performance along many other things.
https://seekingalpha.com/article/4274736-canopy-growth-life-bruce-linton-will-different
Now that the speculation of good announcement is over. The capsules are promised to be at end of the year. I see no plan for trial. I feel that they (PCI pharma) still have problems with producing high quality capsules for cannabis product probably due to issues in micro-encapsulation technology acquired from some where else. AusCann claimed that the first batch has been produced by PCI pharma but they still look at the quality. It shows that AusCann probably has zero technology input into this process.
Don't know. But it's a pretty long wait till end of the year while this stock will drift. However, it's a great run for those entering at the 30s. They would have taken profit though.
- Forums
- ASX - By Stock
- AC8
- Ann: June 2019 Quarterly Activities and Cashflow Reports
Ann: June 2019 Quarterly Activities and Cashflow Reports, page-16
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AC8 (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.62M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AC8 (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online